| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.01 | 1 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0026 | 1 |